Introduction Prior studies have shown that patients with inflammatory bowel disease do not receive preventative measures as compared to the general population. In February 2017, the American College of Gastroenterology (ACG) published comprehensive 14-point guidelines regarding preventive care in IBD. The adherence to these guidelines has not been assessed. Aim We aimed to evaluate adherence to preventive care measures outlined by ACG in IBD patients. Methods We conducted retrospective quality improvement study including IBD patients who had received care at our gastroenterology outpatient clinics between September 15, 2017 to October 15, 2017. Baseline patient characteristics and data regarding adherence to preventative health care measures was noted. Results A total of 94 patients with IBD were included. Mean age was 47.6%. 49% of the patients had Crohn’s disease (CD), while 51% had ulcerative colitis and 34% were males. 58.5% of the patients were on long-term steroid use, while 45.7% and 44.6% of the patients were on immunomodulators and biologics respectively. Adherence rates with preventive care measures are summarized in Table 1. Conclusion Despite comprehensive guidelines, preventive care measures in IBD patients continue to be neglected. There has been debate whether preventative care for these patients is best addressed at the primary care or the gastroenterology clinics. Although our sample size is small, and not a comprehensive data of all IBD patients, our results indicate a large room for improvement. There is a trend towards better preventive care in patients with IBD who have a PCP in addition to a gastroenterologist. Fellow involvement did not affect preventive care in these patients (Table 2). Our next steps include: feedback to our physicians regarding adherence to preventive care, development of electronic health record reminders, placing flyers in patient rooms, and collecting post-intervention data to assess adherence.
